A pan-cancer analysis for the oncogenic role of cyclin-dependent kinase inhibitor 1B in human cancers

ConclusionsThese results showed that the levels of CDKN1B were considerably different in a number of cancer tissues, offering a potential future target for cancer therapy.
Source: Hormones and Cancer - Category: Cancer & Oncology Source Type: research